BriaCell Therapeutics Cor... (BCTXW)
undefined
undefined%
At close: undefined
0.34
-0.03%
After-hours Dec 13, 2024, 04:03 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Revenue - - - - - - - - - - - - - - - - - - -
Cost of Revenue - - - - - - - - - - - - - - - - - - -
Gross Profit - - - - - - - - - - - - - - - - - - -
Operating Income -4.79M -23.27M -15.29M -6.97M -3.61M -4.73M -3.82M - -1.67M -1.44M -437.27K -424.26K -1.20M -1.05M -324.57K -233.87K -114.12K -129.06K -8.58K
Interest Income - 891.21K 136.73K 3.15K - 9.13K 12.27K - 3.63K 7.09K 12.00K 16.90K 38.01K 13.36K 2.90K 2.73K - - -
Pretax Income -4.79M -20.30M -11.55M 3.69M 1.38M 946.42K 1.07M - -1.70M -2.68M -8.15M -368.69K -995.72K -1.09M -903.64K -231.54K - - -
Net Income -4.79M -20.30M -11.55M 3.69M 1.38M 946.42K 1.07M - -1.70M -2.68M -8.15M -368.69K -995.72K -1.08M -900.74K -228.81K -98.93K -116.41K -8.58K
Selling & General & Admin 6.15M 7.94M 7.27M -3.67M -1.37M -932.17K -1.05M - 942.02K 1.33M 436.17K 423.86K 556.06K 1.05M 323.27K 203.86K 114.12K 129.06K 8.58K
Research & Development 27.18M 15.34M 8.02M 1.32M 2.22M 3.74M 2.39M - 723.43K 105.82K - - - - - - - - -
Other Expenses - - - - -58.98K 319.86K -312.92K - - - - - - - - 2.33K - - -
Operating Expenses 33.33M 23.27M -3.39K -3.69M -1.38M -946.42K -1.07M - 1.67M 1.44M 437.27K 424.26K 551.84K 1.05M 324.57K 233.87K 114.12K 129.06K 8.58K
Interest Expense - - 979.00 46.09K 27.00K 23.82K 15.63K - - - - - - - - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - -
Cost & Expenses - 23.27M -3.39K -3.69M -1.38M -946.42K -1.07M - 1.67M 1.44M 437.27K 424.26K 551.84K 1.05M 324.57K 233.87K 114.12K 129.06K 8.58K
Income Tax - -152.62K 979.00 6.58M -72.25K 343.74K -331.40K - 29.24K 1.24M 7.71M -55.56K 443.88K 25.60K 576.17K -2.73K 98.93K 116.41K 8.58K
Shares Outstanding (Basic) 16.45M 15.52M - - - - - - - - - - - - - - - - -
Shares Outstanding (Diluted) 16.45M 15.52M - - - - - - - - - - - - - - - - -
EPS (Basic) -0.29 -1.31 - - - - - - - - - - - - - - - - -
EPS (Diluted) -0.29 -1.31 - - - - - - - - - - - - - - - - -
EBITDA -4.79M -22.37M -11.50M 3.71M 1.40M 960.68K 1.08M - -1.63M -191.61K 7.28M -462.53K -68.23K -1.01M 255.79K -233.72K -114.12K -129.06K -8.58K
Depreciation & Amortization - 15.27K 15.27K 15.26K 15.26K 14.25K 12.97K 232.68 907.21 434.31 1.11K 392.08 1.72K 2.51K 1.29K 154.20 - - -